BRUKER CORPORATION Payments for (Proceeds from) Hedge, Investing Activities
BRUKER CORPORATION (BRKR) reported Payments for (Proceeds from) Hedge, Investing Activities of -$4.80 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromHedgeInvestingActivities · last filed 2025-03-03
- BRUKER CORPORATION payments for (proceeds from) hedge, investing activities for the quarter ending 2024-12-31 was -$1.10M.
- BRUKER CORPORATION payments for (proceeds from) hedge, investing activities for the quarter ending 2024-09-30 was -$1.20M.
- BRUKER CORPORATION payments for (proceeds from) hedge, investing activities for the quarter ending 2024-06-30 was -$1.30M.
- BRUKER CORPORATION payments for (proceeds from) hedge, investing activities for the quarter ending 2024-03-31 was -$1.20M.
- BRUKER CORPORATION payments for (proceeds from) hedge, investing activities for fiscal 2024 was -$4.80M.
- BRUKER CORPORATION payments for (proceeds from) hedge, investing activities for fiscal 2023 was -$6.40M.
- BRUKER CORPORATION payments for (proceeds from) hedge, investing activities for fiscal 2022 was -$6.20M.
- BRUKER CORPORATION payments for (proceeds from) hedge, investing activities for fiscal 2021 was -$10.00M.
| Period end | Payments for (Proceeds from) Hedge, Investing Activities 3 month | Payments for (Proceeds from) Hedge, Investing Activities 6 month | Payments for (Proceeds from) Hedge, Investing Activities 9 month | Payments for (Proceeds from) Hedge, Investing Activities 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$2.30M derived: sum of 2 quarters · filed 2025-03-03 | -$3.60M derived: sum of 3 quarters · filed 2025-03-03 | -$4.80M 10-K · filed 2025-03-03 |
| 2024-09-30 | -$1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$2.50M derived: sum of 2 quarters · filed 2024-11-07 | -$3.70M 10-Q · filed 2024-11-07 | -$5.00M derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$2.50M 10-Q · filed 2024-08-09 | -$3.80M derived: sum of 3 quarters · filed 2025-03-03 | -$5.10M derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-03-31 | -$1.20M 10-Q · filed 2024-05-10 | -$2.50M derived: sum of 2 quarters · filed 2025-03-03 | -$3.80M derived: sum of 3 quarters · filed 2025-03-03 | -$5.20M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$2.60M derived: sum of 2 quarters · filed 2025-03-03 | -$4.00M derived: sum of 3 quarters · filed 2025-03-03 | -$6.40M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$2.70M derived: sum of 2 quarters · filed 2024-11-07 | -$5.10M 10-Q · filed 2024-11-07 | -$6.50M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$3.80M 10-Q · filed 2024-08-09 | -$5.20M derived: sum of 3 quarters · filed 2025-03-03 | -$8.10M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$2.40M 10-Q · filed 2024-05-10 | -$3.80M derived: sum of 2 quarters · filed 2025-03-03 | -$6.70M derived: sum of 3 quarters · filed 2025-03-03 | -$8.30M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$4.30M derived: sum of 2 quarters · filed 2025-03-03 | -$5.90M derived: sum of 3 quarters · filed 2025-03-03 | -$6.20M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$4.50M derived: sum of 2 quarters · filed 2023-11-09 | -$4.80M 10-Q · filed 2023-11-09 | -$6.20M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.90M 10-Q · filed 2023-08-09 | -$3.30M derived: sum of 3 quarters · filed 2024-02-29 | -$10.40M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$300.00K 10-Q · filed 2023-05-10 | -$1.70M derived: sum of 2 quarters · filed 2024-02-29 | -$8.80M derived: sum of 3 quarters · filed 2024-02-29 | -$6.80M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$8.50M derived: sum of 2 quarters · filed 2024-02-29 | -$6.50M derived: sum of 3 quarters · filed 2024-02-29 | -$10.00M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$7.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$5.10M derived: sum of 2 quarters · filed 2022-11-04 | -$8.60M 10-Q · filed 2022-11-04 | -$10.10M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$1.50M 10-Q · filed 2022-08-05 | -$3.00M derived: sum of 3 quarters · filed 2023-03-01 | -$6.60M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$3.50M 10-Q · filed 2022-05-06 | -$5.00M derived: sum of 2 quarters · filed 2023-03-01 | -$8.60M derived: sum of 3 quarters · filed 2023-03-01 | -$10.20M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$5.10M derived: sum of 2 quarters · filed 2023-03-01 | -$6.70M derived: sum of 3 quarters · filed 2023-03-01 | -$8.60M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$5.20M derived: sum of 2 quarters · filed 2021-11-05 | -$7.10M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | -$1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$3.50M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | -$1.90M 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |